SCHEMBL21574223

SCHEMBL21574223

CN(CCOc1ccc(C(N)=O)cc1F)Cc1ccccc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.46
PARP15 Q460N3 2/20 0.46
PARP10 Q53GL7 2/20 0.46
MAOB P27338 1/20 0.46
PARP14 Q460N5 1/20 0.46
SLC6A9 P48067 2/20 0.44
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
THRA P10827 1/20 0.44
THRB P10828 1/20 0.44
ACHE P22303 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ATM Q13315 1/20 0.42
MCHR1 Q99705 2/20 0.41
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19910455 0.90 L3MBTL1 (0.50) L3MBTL1SLC6A9KDM4EALDH1A1THRA
SCHEMBL19910374 0.81 KDM4E (0.46) L3MBTL1SLC6A9KDM4EALDH1A1THRA
SCHEMBL30765139 0.79 PARP10 (0.68) PARP15PARP10MAOBPARP14ALDH1A1
SCHEMBL19910396 0.78 L3MBTL1 (0.61) L3MBTL1KDM4EALDH1A1THRATHRB
SCHEMBL2087136 0.76 MAOB (0.64) L3MBTL1PARP15PARP10MAOBPARP14
SCHEMBL19910479 0.76 LPAR1 (0.55) PARP15PARP10MAOBPARP14KDM4E
SCHEMBL30151541 0.73 MAPK1 (0.50) KDM4EALDH1A1THRATHRBKMT2A
SCHEMBL28897893 0.73 LPAR1 (0.43) L3MBTL1KDM4ETHRATHRBMEN1
SCHEMBL6305137 0.73 MAPK1 (0.45) PARP15PARP10MAOBPARP14THRA
Hydrochloric Acid SCHEMBL30460803 0.72 MAPK1 (0.44) THRATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3288948-B1 FUSED TRICYCLIC PYRAZOLE DERIVATIVES USEFUL FOR MODULATING FARNESOID X RECEPTORS NOVARTIS AG (CH) 2019-11-20 EP disclosed